Viji Finance Ltd

VIJI Finance Limited announced the Board of Directors' recommendation to appoint DDS & Associates, Chartered Accountants (Firm Registration No. 120362W), as the statutory auditors to fill a casual vacancy caused by the resignation of Dharmendra K Agarwal & Co., Chartered Accountants (Firm Registration No. 025525C), subject to member approval. The appointment, effective September 2, 2026, will be until the conclusion of the next annual general meeting, and follows a recommendation from the Audit Committee.

VIJI Finance Limited informed the BSE, NSE, and CSE that its board of directors approved the appointment of M/s. DDS & Associates, Chartered Accountants, as the company's statutory auditors, replacing M/s. Dharmendra K Agarwal & Co., Chartered Accountants, subject to member approval within three months. The appointment, effective from the date of approval until the next annual general meeting, was made at a board meeting held on September 2, 2026.

VIJI Finance Limited announced the allotment of 10,00,000 equity shares, or 1 crore, at a price of Rs 2.80 per share to a non-promoter warrant holder, following the receipt of the remaining 75% of the issue price, totaling Rs 21,00,000. This completes the conversion of all 88,50,000 warrants initially allotted in June 2026, increasing the company's issued, subscribed, and paid-up capital from Rs 22,10,00,000 to Rs 23,10,00,000.

VIJI Finance Limited announced the allotment of 10,00,000 equity shares, or 1 crore, at a price of Rs 2.80 per share to a non-promoter warrant holder, following the receipt of the remaining 75% of the issue price, totaling Rs 21,00,000. This completes the conversion of all 88,50,000 warrants initially allotted on June 16, 2026, bringing the company's issued, subscribed, and paid-up capital to Rs 23,10,00,000, consisting of 23,10,00,000 fully paid-up equity shares.

Vij Bioscience Private Limited announced that at its 32nd Annual General Meeting held on August 13, 2026, the company approved an increase in authorized capital and confirmed several director appointments. These include the appointment of Mr. Aryaman Kothari as a Whole-Time Director, Mr. Prakash Muksiya as an Additional Non-Executive Independent Director, and the re-appointment of Ms. Sakshi Chourasiya as a Non-Executive Independent Director for a second term. Mr. Aryaman Kothari, son of Chairman & Managing Director Vijay Kothari, possesses over six years of experience in finance and business management. Mr. Prakash Muksiya brings 15 years of experience in cooperative society management, while Ms. Sakshi Chourasiya has 18 years of experience in education and operations. All appointees have confirmed they are not debarred from accessing capital markets.

Vij Bioscience Private Limited announced that its board approved several changes at its 32nd Annual General Meeting on August 13, 2026. These include the appointment of Mr. Aryaman Kothari as a Whole-time Director, Mr. Prakash Muksiya as a Non-Executive Independent Director, and the re-appointment of Ms. Sakshi Chourasiya as a Non-Executive Independent Director for a second term. The board also approved an increase in authorized capital and ratified the appointment of auditors. Additionally, the company increased its authorized capital from Rs [amount] to Rs [amount].

Vijji Finance Limited announced the allotment of 1,50,00,000 equity shares, or 1.5 crore, at Rs 2.80 per share to two non-promoter warrant holders, following the receipt of the remaining 75% of the issue price, aggregating to Rs 3,15,00,000. The allotment is part of a larger preferential allotment process that began June 16, 2026, when 8,85,00,000 warrants were initially allotted, with 6,35,00,000 equity shares already issued to 16 warrant holders. The company's issued, subscribed, and paid-up capital has increased from Rs 20.60 crore to Rs 22.10 crore as a result of the latest allotment.

Vijji Finance Limited announced the allotment of 1,50,00,000 equity shares, or 1.5 crore, at a price of Rs 2.80 per share to two warrant holders belonging to the non-promoter category, following the receipt of the remaining 75% of the issue price, aggregating to Rs 3,15,00,000. The allotment is part of a larger conversion of warrants initially allotted on June 16, 2026, and increases the company’s issued, subscribed, and paid-up capital from Rs 20.60 crore to Rs 22.10 crore.

Viji Finance announced that the 32th Annual General Meeting(AGM) of the company will be held on 13 August 2026.

Net profit of Viji Finance reported to Rs 1.14 crore in the quarter ended June 2026 as against net loss of Rs 0.33 crore during the previous quarter ended June 2025. Sales rose 56.14% to Rs 0.89 crore in the quarter ended June 2026 as against Rs 0.57 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales0.890.57 56 OPM %67.42-28.07 - PBDT1.61-0.25 LP PBT1.53-0.33 LP NP1.14-0.33 LP Powered by Capital Market - Live